George Hill
Stock Analyst at Deutsche Bank
(2.94)
# 1,322
Out of 5,182 analysts
194
Total ratings
52.14%
Success rate
5.35%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $120 → $128 | $81.95 | +56.19% | 19 | Mar 19, 2026 | |
| WAY Waystar Holding | Maintains: Buy | $42 → $37 | $22.65 | +63.36% | 3 | Mar 12, 2026 | |
| TDOC Teladoc Health | Upgrades: Buy | $11 | $5.27 | +108.73% | 19 | Mar 10, 2026 | |
| HIMS Hims & Hers Health | Maintains: Hold | $25 → $28 | $19.39 | +44.40% | 5 | Mar 10, 2026 | |
| ELV Elevance Health | Downgrades: Hold | $332 → $320 | $318.23 | +0.56% | 3 | Dec 19, 2025 | |
| HUM Humana | Maintains: Hold | $250 → $231 | $198.39 | +16.44% | 12 | Nov 7, 2025 | |
| MCK McKesson | Maintains: Buy | $775 → $856 | $871.18 | -1.74% | 8 | Sep 24, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $521 → $362 | $305.98 | +18.31% | 22 | May 14, 2025 | |
| CVS CVS Health | Maintains: Buy | $66 → $70 | $78.79 | -11.16% | 7 | Feb 14, 2025 | |
| AGL agilon health | Maintains: Hold | $100 → $50 | $18.47 | +170.71% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $398 → $394 | $277.56 | +41.95% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $119 → $124 | $215.13 | -42.36% | 12 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $1.38 | +44.93% | 14 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $1.04 | +380.77% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $87 | $37.28 | +133.37% | 10 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $147.55 | +139.24% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $222.97 | +111.24% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $2.14 | +273.83% | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $172.54 | +44.89% | 4 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $106.54 | +120.57% | 5 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $175.07 | +90.78% | 5 | Feb 18, 2021 |
HealthEquity
Mar 19, 2026
Maintains: Buy
Price Target: $120 → $128
Current: $81.95
Upside: +56.19%
Waystar Holding
Mar 12, 2026
Maintains: Buy
Price Target: $42 → $37
Current: $22.65
Upside: +63.36%
Teladoc Health
Mar 10, 2026
Upgrades: Buy
Price Target: $11
Current: $5.27
Upside: +108.73%
Hims & Hers Health
Mar 10, 2026
Maintains: Hold
Price Target: $25 → $28
Current: $19.39
Upside: +44.40%
Elevance Health
Dec 19, 2025
Downgrades: Hold
Price Target: $332 → $320
Current: $318.23
Upside: +0.56%
Humana
Nov 7, 2025
Maintains: Hold
Price Target: $250 → $231
Current: $198.39
Upside: +16.44%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $775 → $856
Current: $871.18
Upside: -1.74%
UnitedHealth Group
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $305.98
Upside: +18.31%
CVS Health
Feb 14, 2025
Maintains: Buy
Price Target: $66 → $70
Current: $78.79
Upside: -11.16%
agilon health
Nov 8, 2024
Maintains: Hold
Price Target: $100 → $50
Current: $18.47
Upside: +170.71%
Nov 4, 2024
Maintains: Buy
Price Target: $398 → $394
Current: $277.56
Upside: +41.95%
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $215.13
Upside: -42.36%
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $1.38
Upside: +44.93%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $1.04
Upside: +380.77%
Aug 2, 2024
Maintains: Hold
Price Target: $82 → $87
Current: $37.28
Upside: +133.37%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $147.55
Upside: +139.24%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $222.97
Upside: +111.24%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $2.14
Upside: +273.83%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $172.54
Upside: +44.89%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $106.54
Upside: +120.57%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $175.07
Upside: +90.78%